These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 7879811)

  • 1. Inaccuracy in fluoxetine comparison.
    Muilenburg ND
    Am J Hosp Pharm; 1994 Dec; 51(23):2969-70. PubMed ID: 7879811
    [No Abstract]   [Full Text] [Related]  

  • 2. [A test for using meta-analysis to evaluate antidepressive effects of fluoxetine].
    Jarema M
    Psychiatr Pol; 1996; 30(4):569-81. PubMed ID: 8975258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluoxetine-tricyclic combinations.
    Zelwer A
    Aust N Z J Psychiatry; 1993 Jun; 27(2):350, 352. PubMed ID: 8363551
    [No Abstract]   [Full Text] [Related]  

  • 4. Effectiveness of fluoxetine and doxepin in treatment of melancholia in depressed patients.
    Sandor P; Baker B; Irvine J; Dorian P; McKessok D; Mendlowitz S
    Depress Anxiety; 1998; 7(2):69-72. PubMed ID: 9614594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficacy of fluoxetine as an antidepressant in the short and long term.
    Montgomery SA
    Int Clin Psychopharmacol; 1989 Jan; 4 Suppl 1():113-9. PubMed ID: 2644336
    [No Abstract]   [Full Text] [Related]  

  • 6. Fluoxetine versus trimipramine in the treatment of depression in geriatric patients.
    Wehmeier PM; Kluge M; Maras A; Riemann D; Berger M; Kohnen R; Dittmann RW; Gattaz WF
    Pharmacopsychiatry; 2005 Jan; 38(1):13-6. PubMed ID: 15706460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluoxetine for depression.
    Med Lett Drugs Ther; 1988 Apr; 30(764):45-7. PubMed ID: 3258399
    [No Abstract]   [Full Text] [Related]  

  • 8. Fluoxetine (prozac) in depresion of adults.
    Kocur J; Rydzynski Z; Duszyk S; Gruszczynski W; Trendak W
    Homeost Health Dis; 1991; 33(5-6):295. PubMed ID: 18265505
    [No Abstract]   [Full Text] [Related]  

  • 9. Absence of a relationship between adverse events and suicidality during pharmacotherapy for depression.
    Tollefson GD; Rampey AH; Beasley CM; Enas GG; Potvin JH
    J Clin Psychopharmacol; 1994 Jun; 14(3):163-9. PubMed ID: 8027412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Course of psychomotor agitation during pharmacotherapy of depression: analysis from double-blind controlled trials with fluoxetine.
    Tollefson GD; Sayler ME
    Depress Anxiety; 1996-1997; 4(6):294-311. PubMed ID: 9166658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Open trial study of a combined antidepressant (amitryptiline, perphenazine, diazepam) versus fluoxetine or imipramine in ambulatory depressed patients.
    Diaz A; Fouilloux C; Ortiz S
    Proc West Pharmacol Soc; 2002; 45():154-5. PubMed ID: 12434564
    [No Abstract]   [Full Text] [Related]  

  • 12. Atypical depression, atypical temperament and a differential antidepressant response to fluoxetine and nortriptyline.
    Joyce PR; Mulder RT; McKenzie JM; Luty SE; Cloninger CR
    Depress Anxiety; 2004; 19(3):180-6. PubMed ID: 15129420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of the combination of fluoxetine and perphenazine in the treatment of psychotic depression.
    Rothschild AJ; Samson JA; Bessette MP; Carter-Campbell JT
    J Clin Psychiatry; 1993 Sep; 54(9):338-42. PubMed ID: 8104930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Are tricyclic antidepressants unsuitable in depression?].
    Runeberg S
    Lakartidningen; 1997 Sep; 94(37):3127-8. PubMed ID: 9340451
    [No Abstract]   [Full Text] [Related]  

  • 15. Fluoxetine and imipramine: are there differences in cost-utility for depression in primary care?
    Serrano-Blanco A; Suárez D; Pinto-Meza A; Peñarrubia MT; Haro JM;
    J Eval Clin Pract; 2009 Feb; 15(1):195-203. PubMed ID: 19239602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Changes in the ECG in the course of treatment of endogenous depression with tricyclic antidepressive agents].
    Bilikiewicz A; Januszkiewicz-Grabiasowa A; Deptulski T; Taraszkiewicz W; Wojtowicz M
    Psychiatr Pol; 1977; 11(5):511-7. PubMed ID: 601119
    [No Abstract]   [Full Text] [Related]  

  • 17. Fluoxetine: an alternative to the tricyclics in the treatment of major depression?
    Tacke U
    Am J Med Sci; 1989 Aug; 298(2):126-9. PubMed ID: 2669476
    [No Abstract]   [Full Text] [Related]  

  • 18. Depression in the elderly: principles of tricyclic antidepressant treatment.
    Elmore JL; Rochford J
    J Med Soc N J; 1983 Mar; 80(3):173-6. PubMed ID: 6575178
    [No Abstract]   [Full Text] [Related]  

  • 19. Fluoxetine, placebo, and tricyclic antidepressants in major depression with and without anxious features.
    Tollefson GD; Holman SL; Sayler ME; Potvin JH
    J Clin Psychiatry; 1994 Feb; 55(2):50-9. PubMed ID: 8077155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serious adverse effects of combining fluoxetine and tricyclic antidepressants.
    Preskorn SH; Beber JH; Faul JC; Hirschfeld RM
    Am J Psychiatry; 1990 Apr; 147(4):532. PubMed ID: 2107764
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.